Vir Biotechnology (VIR) Tax Provisions (2018 - 2026)
Vir Biotechnology (VIR) posted Tax Provisions of $170000.0 for Q1 2026, up 224.09% sequentially from -$137000.0 in Q4 2025, and up 962.5% YoY from $16000.0 in Q1 2025.
Vir Biotechnology (VIR) Tax Provisions (2018 - 2026) Analysis & Trends
Vir Biotechnology has reported Tax Provisions for 9 years, with the latest figure at $170000.0 in Q1 2026.
- Quarterly Tax Provisions rose 962.5% year-over-year to $170000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $371000.0 (up 126.41% YoY) and the FY2025 annual result came in at $217000.0, up 118.95% from the prior year.
- Tax Provisions grew to $170000.0 in Q1 2026 per VIR's latest filing, from -$137000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $403.3 million in Q1 2022 and troughed at -$157.2 million in Q2 2022.
- A 5-year average of $13.2 million and a median of -$86000.0 in 2024 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 205658.16% in 2022, down 296756.6% in 2022.
- Over 5 years, Tax Provisions stood at -$50.0 million in 2022, then soared by 90.44% to -$4.8 million in 2023, then surged by 98.2% to -$86000.0 in 2024, then sank by 59.3% to -$137000.0 in 2025, then surged by 224.09% to $170000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $170000.0, -$137000.0, and $168000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Vir Biotechnology | 1.56 Bn | 1.56 Bn | 238.95 Mn | 179,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 179,000.00 |
| Mar 31, 2026 | 170,000.00 |
| Dec 31, 2025 | -137,000.00 |
| Sep 30, 2025 | 168,000.00 |
| Jun 30, 2025 | 170,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | -86,000.00 |
| Sep 30, 2024 | 177,000.00 |
| Jun 30, 2024 | -1.51 Mn |
| Mar 31, 2024 | 276,000.00 |
| Dec 31, 2023 | -4.78 Mn |
| Sep 30, 2023 | -3.21 Mn |
| Jun 30, 2023 | -2.85 Mn |
| Mar 31, 2023 | -2.23 Mn |
| Dec 31, 2022 | -50.04 Mn |
| Sep 30, 2022 | 42.42 Mn |
| Jun 30, 2022 | -157.23 Mn |
| Mar 31, 2022 | 403.29 Mn |
| Dec 31, 2021 | 20.64 Mn |
| Sep 30, 2021 | 334,000.00 |